| Bioactivity | Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists[1]. |
| Name | Runcaciguat |
| CAS | 1402936-61-1 |
| Formula | C23H22Cl2F3NO3 |
| Molar Mass | 488.33 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Barbara ALBRECHT-KÜPPER, et al. Selective partial adenosine a1 receptor agonists in combination with soluble guanylyl cyclase (sgc) stimulators and/or activators. WO2018153899A1. |
Runcaciguat
CAS: 1402936-61-1 F: C23H22Cl2F3NO3 W: 488.33
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.